Cargando…
Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
Autores principales: | Slevin, Finbar, Rodda, Sree Lakshmi, Bownes, Peter, Murray, Louise, Bottomley, David, Melody, Clare, Adiotomre, Ese, Al-Qaisieh, Bashar, Dugdale, Emma, Hulson, Oliver, Mason, Joshua, Smith, Jonathan, Henry, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327822/ https://www.ncbi.nlm.nih.gov/pubmed/32637660 http://dx.doi.org/10.1016/j.ctro.2020.06.001 |
Ejemplares similares
-
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020) -
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
por: Slevin, Finbar, et al.
Publicado: (2019) -
Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020) -
Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020) -
High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)